Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Urology"
DOI: 10.1080/21681805.2016.1250810
Abstract: Abstract Objective: This study aimed to assess the role of tadalafil, a phosphodiesterase type 5 inhibitor (PDE5-I), in recovery of lower urinary tract symptoms (LUTS) after robot-assisted radical prostatectomy (RARP). Materials and methods: All patients… read more here.
Keywords: phosphodiesterase type; patients taking; treatment; study ... See more keywords